Skip to content

Fortrea Holdings

US · FTRE #2796 by market cap Listed 2023
18.55 -1.60 -7.94%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Recent news

  • Baird Maintains Fortrea Holdings(FTRE.US) With Buy Rating, Raises Target Price to $26
    Market Newswire · 2026/10/30
  • Rating change
    UBS Initiates Fortrea Holdings(FTRE.US) With Hold Rating, Announces Target Price $22
    Market Newswire · 2026/9/30
  • TD Cowen Maintains Fortrea Holdings(FTRE.US) With Buy Rating, Raises Target Price to $26
    Market Newswire · 2026/11/3
  • Rating change
    Analysts' Top Healthcare Picks: Revolution Medicines (RVMD), Fortrea Holdings Inc. (FTRE)
    TipRanks · 2026/9/3
  • Rating change
    Deutsche Bank Upgrades Fortrea Holdings(FTRE.US) to Buy Rating, Raises Target Price to $25
    Market Newswire · 2026/10/15
  • Rating change
    Barclays Maintains Fortrea Holdings(FTRE.US) With Hold Rating, Maintains Target Price $22
    Market Newswire · 2026/9/3
  • Rating change
    William Blair Maintains Fortrea Holdings(FTRE.US) With Hold Rating
    Market Newswire · 2026/9/10
  • A Quick Look at Today's Ratings for Fortrea Holdings(FTRE.US), With a Forecast Between $26 to $28
    Market Newswire · 2026/10/31
  • Rating change
    BofA Securities Maintains Fortrea Holdings(FTRE.US) With Sell Rating, Announces Target Price $15.5
    Market Newswire · 2026/10/9
  • Rating change
    Barclays Maintains Fortrea Holdings(FTRE.US) With Buy Rating, Raises Target Price to $26
    Market Newswire · 2026/10/30
  • Rating change
    UBS Maintains Fortrea Holdings(FTRE.US) With Hold Rating, Maintains Target Price $22
    Market Newswire · 2026/10/3
  • Rating change
    UBS Maintains Fortrea Holdings(FTRE.US) With Hold Rating, Raises Target Price to $24
    Market Newswire · 2026/10/20
  • Rating change
    Truist Financial Maintains Fortrea Holdings(FTRE.US) With Buy Rating
    Market Newswire · 2026/9/3
  • Rating change
    Analysts Offer Insights on Healthcare Companies: Fortrea Holdings Inc. (FTRE) and Immunome (IMNM)
    TipRanks · 2026/9/10
  • Rating change
    Analysts Offer Insights on Healthcare Companies: Fortrea Holdings Inc. (FTRE), AgomAb Therapeutics NV ADR (AGMB) and Sana Biotechnology (SANA)
    TipRanks · 2026/8/17
  • Barclays Maintains Fortrea Holdings(FTRE.US) With Buy Rating, Maintains Target Price $26
    Market Newswire · 2026/10/30
  • Mizuho Securities Downgrades Fortrea Holdings(FTRE.US) to Sell Rating, Raises Target Price to $19
    Market Newswire · 2026/11/11
  • Rating change
    Analysts Have Conflicting Sentiments on These Healthcare Companies: Fortrea Holdings Inc. (FTRE), Medtronic (MDT) and Immunic (IMUX)
    TipRanks · 2026/9/2
  • Rating change
    Analysts Have Conflicting Sentiments on These Healthcare Companies: Phreesia (PHR), Alpha Tau (DRTS) and Fortrea Holdings Inc. (FTRE)
    TipRanks · 2026/9/3
  • Rating change
    Barclays Upgrades Fortrea Holdings(FTRE.US) to Buy Rating, Raises Target Price to $23
    Market Newswire · 2026/10/6
  • Rating change
    TD Cowen Maintains Fortrea Holdings(FTRE.US) With Buy Rating, Maintains Target Price $23
    Market Newswire · 2026/8/4
  • GUIDANCE: (FTRE) Fortrea Expects 2026 Revenue Range $2.67B to $2.69B, Vs. FactSet Est of $2.66B
    MT Newswires · 2026/10/29
  • Rating change
    Analysts Offer Insights on Healthcare Companies: Teladoc (TDOC), Fortrea Holdings Inc. (FTRE) and UniQure (QURE)
    TipRanks · 2026/7/30
  • Rating change
    A Quick Look at Today's Ratings for Fortrea Holdings(FTRE.US), With a Forecast Between $22 to $26
    Market Newswire · 2026/7/31
  • Rating change
    TD Cowen Maintains Fortrea Holdings(FTRE.US) With Buy Rating, Raises Target Price to $23
    Market Newswire · 2026/8/4

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-11-20 19:30:00 · For reference only, not investment advice and not tailored to your situation.

Fortrea Holdings discussion 0 comments

Add a comment